October 10, 2025

Personalis, Inc. (PSNL) Stock Analysis: Navigating the Tumultuous Waters of Diagnostics & Research

Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector, specifically within the diagnostics and research industry, is currently trading at $8.61, nudging slightly downward by 0.01% in recent..

Avanos Medical, Inc. (AVNS) Stock Analysis: Challenges and Opportunities Amidst Potential Growth

Investors eyeing the healthcare sector may want to consider the nuanced profile of Avanos Medical, Inc. (NYSE: AVNS), a medical device company with a diverse range of product offerings aimed..

Weave Communications, Inc. (WEAV) Stock Analysis: 70% Upside Potential Amid Healthcare Innovations

Investors interested in the healthcare technology space may find Weave Communications, Inc. (NYSE: WEAV) an intriguing opportunity, particularly given its substantial 70.91% potential upside. This Lehi, Utah-based company, with a..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 14.98% Potential Upside Amid Healthcare Sector Challenges

Community Health Systems, Inc. (NYSE: CYH) is a key player in the healthcare sector, specifically within the medical care facilities industry in the United States. Despite being a significant provider..

CeriBell, Inc. (CBLL) Stock Analysis: Robust Revenue Growth and 134% Potential Upside Captivate Investors

CeriBell, Inc. (NASDAQ: CBLL), operating in the healthcare sector’s medical device industry, has been gaining significant attention from investors, showcasing a compelling blend of innovative technology and promising financial indicators...

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Potential 42.68% Upside with Promising Biopharma Innovations

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, has recently caught the attention of investors with its promising pipeline of novel therapeutics aimed at treating disorders linked to dysfunctional..

Zevra Therapeutics (ZVRA) Investor Outlook: Analyzing 114% Potential Upside in Biotech

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is capturing the spotlight in the biotech sector with its robust pipeline focused on rare diseases. With a current market capitalization of $607.38 million, this..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 17% Potential Upside in the Healthcare Sector

Enhabit, Inc. (EHAB), a key player in the healthcare sector based in Dallas, Texas, is garnering attention from investors looking for potential growth in the medical care facilities industry. As..

Auna SA (AUNA) Stock Analysis: Exploring a Potential 83.64% Upside for Healthcare Investors

Auna SA (AUNA), a notable player in the healthcare sector, is gaining attention from investors due to its potential for significant upside. With its headquarters in Luxembourg, Auna operates a..

Bioventus Inc. (BVS) Stock Analysis: Unlocking 122.56% Potential Upside in Healthcare Innovation

Bioventus Inc. (NASDAQ: BVS) is making waves in the healthcare sector with its innovative approach to medical devices, particularly in the realm of pain relief and musculoskeletal therapies. Headquartered in..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Potential 163% Upside in Biotech

For investors with an eye on the biotechnology sector, Kura Oncology, Inc. (NASDAQ: KURA) presents a compelling opportunity amid the dynamic landscape of cancer therapeutics. With a market capitalization of..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring 100% Upside Potential Amid Biotech Innovations

Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors with its innovative approach to transforming drug discovery processes within the biotechnology sector. As a clinical-stage precision medicines company,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges with Strategic Solutions

AMN Healthcare Services Inc (NYSE: AMN) stands as a key player in the U.S. healthcare staffing and solutions sector, providing a wide range of technology-enabled workforce services. Despite facing significant..

Talkspace, Inc. (TALK) Stock Analysis: A 64.95% Potential Upside Beckons Investors

Talkspace, Inc. (TALK) is steadily carving its niche within the healthcare sector, specifically in the health information services industry. This virtual behavioral healthcare company has been making waves by offering..

Akso Health Group (AHG) Investor Outlook: Exploring the 415.80% Revenue Surge Amidst Challenging Metrics

Investors with a keen eye on the healthcare sector, particularly in medical distribution, may find Akso Health Group (NASDAQ: AHG) an intriguing case study. With its roots in social e-commerce..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Uncovering a 35.76% Potential Upside in Biotech Innovation

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a dynamic player in the burgeoning field of gene editing, presents a compelling case for investors with a keen eye on the biotechnology sector. With..

GH Research PLC (GHRS) Investor Outlook: Potential 149% Upside in the Biotech Sector

GH Research PLC (NASDAQ: GHRS), an innovative player in the biotechnology sector, is generating significant buzz among investors with its promising pipeline of treatments for depression and other psychiatric disorders...

Savara Inc. (SVRA) Investor Outlook: Exploring a 186% Upside Potential in the Biotech Sector

Savara Inc. (NASDAQ: SVRA), a Langhorne, Pennsylvania-based biopharmaceutical company, has garnered significant attention in the healthcare sector, particularly within the biotechnology industry. With a focus on rare respiratory diseases, Savara’s..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A 315% Potential Upside in the Biotechnology Sector

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a pioneering entity in the healthcare sector, specifically within the biotechnology industry, is capturing the attention of investors with its remarkable potential upside of 315.53%...

Embecta Corp. (EMBC) Stock Analysis: Unveiling a 22.64% Potential Upside Amid Promising Revenue Growth

Embecta Corp. (NASDAQ: EMBC), a notable player in the healthcare sector, specializes in medical instruments and supplies, focusing on innovative solutions for diabetes management. With a market capitalization of $794.81..

Search

Funds

October 10, 2025

Search

Funds

October 10, 2025

FTSE 100

Funds